Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.

Singh R, Almutairi M, Alm RA, Lahiri SD, San Martin M, Chen A, Ambler JE.

J Antimicrob Chemother. 2017 Oct 1;72(10):2796-2803. doi: 10.1093/jac/dkx214.

PMID:
29091195
2.

New Antimicrobial Agents  …  but No Susceptibility Tests!

Ambler JE, Krause KM, Steenbergen JN, Scangarella-Oman NE, Miller LA, Bhagwat SS, Serio AW, Chesnel L, Mahoney NM, Motyl MR, Critchley IA, Iaconis JP, Stone GG, Alder J, Xerri L, McCurdy SP, van Veenhuyzen DF, Grossman T, Echols RM, Williams G, Bradford PA.

Clin Infect Dis. 2016 Dec 1;63(11):1530-1531. Epub 2016 Aug 31. No abstract available.

PMID:
27581762
3.

In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program.

Biedenbach DJ, Alm RA, Lahiri SD, Reiszner E, Hoban DJ, Sahm DF, Bouchillon SK, Ambler JE.

Antimicrob Agents Chemother. 2015 Oct 26;60(1):343-7. doi: 10.1128/AAC.01867-15. Print 2016 Jan.

4.

In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolates Collected in 2012 from Latin American Countries as Part of the AWARE Surveillance Program.

Biedenbach DJ, Hoban DJ, Reiszner E, Lahiri SD, Alm RA, Sahm DF, Bouchillon SK, Ambler JE.

Antimicrob Agents Chemother. 2015 Dec;59(12):7873-7. doi: 10.1128/AAC.01833-15. Epub 2015 Sep 28.

5.

Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline.

Lahiri SD, McLaughlin RE, Whiteaker JD, Ambler JE, Alm RA.

J Antimicrob Chemother. 2015 Sep;70(9):2488-98. doi: 10.1093/jac/dkv131. Epub 2015 Jun 4.

PMID:
26045529
6.

Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-μg disk.

Koeth LM, Matuschek E, Kahlmeter G, Alm RA, Ambler JE.

Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1511-7. doi: 10.1007/s10096-014-2089-8. Epub 2014 Apr 18.

PMID:
24744220
7.
9.
10.
12.
13.

Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland.

Goldsmith CE, Moore JE, Murphy PG, Ambler JE.

J Antimicrob Chemother. 1998 Mar;41(3):420-1. No abstract available.

PMID:
9578174
14.

Post-UV survival of Escherichia coli strains carrying more than one UV-sensitising plasmid.

Ambler JE, Pinney RJ.

Mutat Res. 1996 Apr 13;351(2):181-6.

PMID:
8622712
15.

Mupirocin-resistant methicillin-resistant Staphylococcus aureus.

Ambler JE, Drabu YJ.

J Hosp Infect. 1996 Jan;32(1):71-82. No abstract available.

PMID:
8904376
17.

Mutator plasmid in a nalidixic acid-resistant strain of Shigella dysenteriae type 1.

Ambler JE, Drabu YJ, Blakemore PH, Pinney RJ.

J Antimicrob Chemother. 1993 Jun;31(6):831-9.

PMID:
8360123
18.

Differentiating under- and overcontrolled behavior of adolescent outpatients with the High School Personality Questionnaire.

Gallucci NT, Ambler JE.

Psychol Rep. 1987 Feb;60(1):335-8. No abstract available.

PMID:
3562732
19.

Iron-stress Response in Mixed and Monocultures of Soybean Cultivars.

Ambler JE, Brown JC.

Plant Physiol. 1972 Dec;50(6):675-8.

20.

Effect of zinc on translocation of iron in soybean plants.

Ambler JE, Brown JC, Gauch HG.

Plant Physiol. 1970 Aug;46(2):320-3.

Supplemental Content

Loading ...
Support Center